Inhibrx Biosciences (INBX) Interest Coverage Ratio (2023 - 2025)

Inhibrx Biosciences (INBX) reported Interest Coverage Ratio of 9.71 for Q4 2025, up 8.66% quarter-over-quarter from 10.63 in Q3 2025.

Inhibrx Biosciences (INBX) Interest Coverage Ratio (2023 - 2025) Analysis & Trends

Inhibrx Biosciences (INBX) has 3 years of Interest Coverage Ratio data on file, last reported at 9.71 in Q4 2025.

Interest Coverage Ratio for Q4 2025 came in at 9.71, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was 11.07 (up 54.94% YoY), and the FY2025 annual result was 11.07, up 54.94% from the prior year.
Interest Coverage Ratio improved to 9.71 in Q4 2025 per INBX's latest filing, from 10.63 in the prior quarter.
Over five years, Interest Coverage Ratio peaked at 5.23 in Q2 2023 and troughed at 30.01 in Q2 2024.
A 3-year average of 11.74 and a median of 9.71 in 2025 frame the typical range for Interest Coverage Ratio.
The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio slumped 473.91% in 2024, then jumped 70.95% in 2025.
A 3-year view of Interest Coverage Ratio shows it stood at 10.74 in 2023, then tumbled by 179.53% to 30.01 in 2024, then soared by 67.65% to 9.71 in 2025.
Business Quant data shows INBX's Interest Coverage Ratio at 9.71 in Q4 2025, 10.63 in Q3 2025, and 8.72 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	3.58
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	11.50
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-258.33
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	547.67
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	11.79
10	Inhibrx Biosciences	186.16 Mn	186.16 Mn	-	-9.71

Download Data